Emergency Use Authorization for COVID-19 antibody
The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy
Premier Specialty Network Allergy, Asthma & Immunology Articles
The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy
Coronavirus (COVID-19) : History, Update & Action Plan from Dr. Robert Jackson
Dr. Kevin Latinis, M.D. PhD gives an update on his plans for dealing with the Coronavirus (COVID-19) and his patients.
The Danolyte Global Company in Midwestern United States, Overland Park, Kansas has the hypochlorous acid technology that can slow this pandemic down.
Coronavirus disease 2019 (COVID-19) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.
Presentation announcement - coronavirus pandemic - ATSU CME Conference - March, 2020.
Results of a new study on mice and a phase 1 trial of humans suggest that prolonged cycles of fasting - for 2-4 days at a time - not only protect against toxic effects of chemotherapy, but also trigger stem cell regeneration of new immune cells and clearing out of old, damaged cells.
Premier Specialty Network helps provide Rheumatology, Ear, Nose and Throat and Allergy and Immunology Clinics at DCH